HAUGSTEN, Ellen Margrethe, Vigdis SØRENSEN, Michaela BOSÁKOVÁ, Gustavo Antonio de SOUZA, Pavel KREJČÍ, Antoni WIEDLOCHA a Jørgen WESCHE. Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport. Journal of Proteome Research. Washington: American Chemical Society, roč. 15, č. 10, s. 3841-3855. ISSN 1535-3893. doi:10.1021/acs.jproteome.6b00652. 2016.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Proximity Labeling Reveals Molecular Determinants of FGFR4 Endosomal Transport
Autoři HAUGSTEN, Ellen Margrethe (578 Norsko), Vigdis SØRENSEN (578 Norsko), Michaela BOSÁKOVÁ (203 Česká republika, domácí), Gustavo Antonio de SOUZA (76 Brazílie), Pavel KREJČÍ (203 Česká republika, garant, domácí), Antoni WIEDLOCHA (578 Norsko) a Jørgen WESCHE (578 Norsko).
Vydání Journal of Proteome Research, Washington, American Chemical Society, 2016, 1535-3893.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor Genetika a molekulární biologie
Stát vydavatele Spojené státy
Utajení není předmětem státního či obchodního tajemství
Impakt faktor Impact factor: 4.268
Kód RIV RIV/00216224:14110/16:00091282
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.1021/acs.jproteome.6b00652
UT WoS 000385054100035
Klíčová slova anglicky FGFR4; FGF1; BioID; quantitative MS; confocal microscopy; three-dimensional structured illumination microscopy; endocytosis; clathrin; recycling compartment; trans-Golgi network
Štítky EL OK
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 21. 11. 2016 15:46.
Anotace
The fibroblast growth factor receptors (FGFRs) are important oncogenes promoting tumor progression in many types of cancer, such as breast, bladder, and lung cancer as well as multiple myeloma and rhabdomyosarcoma. However, little is known about how these receptors are internalized and down-regulated in cells. We have here applied proximity biotin labeling to identify proteins involved in FGFR4 signaling and trafficking. For this purpose we fused a mutated biotin ligase, BirA*, to the C-terminal tail of FGFR4 (FGFR4-BirA*) and the fusion protein was stably expressed in U2OS cells. Upon addition of biotin to these cells, proteins in proximity to the FGFR4-BirA* fusion protein became biotinylated and could be isolated and identified by quantitative mass spectrometry. We identified in total 291 proteins, including 80 proteins that were enriched in samples where the receptor was activated by the ligand (FGF1), among them several proteins previously found to be involved in FGFR signaling (e.g., FRS2, PLC gamma, RSK2 and NCK2). Interestingly, many of the identified proteins were implicated in endosomal transport, and by precise annotation we were able to trace the intracellular pathways of activated FGFR4. Validating the data by confocal and three-dimensional structured illumination microscopy analysis, we concluded that FGFR4 uses clathrin-mediated endocytosis for internalization and is further sorted from early endosomes to the recycling compartment and the trans-Golgi network. Depletion of cells for clathrin heavy chain led to accumulation of FGFR4 at the cell surface and increased levels of active FGFR4 and PLC?, while AKT and ERK signaling was diminished, demonstrating that functional clathrin-mediated endocytosis is required for proper FGFR4 signaling. Thus, this study reveals proteins and pathways involved in FGFR4 transport and signaling that provide possible targets and opportunities for therapeutic intervention in FGFR4 aberrant cancer.
Návaznosti
EE2.3.30.0009, projekt VaVNázev: Zaměstnáním čerstvých absolventů doktorského studia k vědecké excelenci
VytisknoutZobrazeno: 23. 4. 2024 10:14